Consensus Revvity, Inc.

Stocks

RVTY

US7140461093

Advanced Medical Equipment & Technology

Market Closed - NYSE 21:04:11 14/10/2026 BST			5-day change	1st Jan Change
152.12 ^USD	-1.91%		-0.96%	+57.23%

10-14	JPMorgan Adjusts Price Target on Revvity to $155 From $110	MT
10-13	TD Cowen Adjusts Price Target on Revvity to $175 From $130	MT

Evolution of the Average Target: Revvity, Inc.

Evolution of the Target Price: Revvity, Inc.

Changes in Analyst Recommendations: Revvity, Inc.

5a0206626eed72a923e925dc0ac.Ovx80fpan5FdpldR-jIvtEdzKK1cAqUYVKqXiqsF5HE.eMUwqZU71rw6zhAnj2JO5BI0XNk6bdY1G8KlufN_uyZcjE6FzR_c_GzNGg~dfa21cb6a5b590f6c6415d5cae5e338e

Analysts' recommendations: Revvity, Inc.

10-14	JPMorgan Adjusts Price Target on Revvity to $155 From $110	MT
10-13	TD Cowen Adjusts Price Target on Revvity to $175 From $130	MT
10-08	Baird Adjusts Price Target on Revvity to $164 From $144	MT
10-07	Evercore ISI Adjusts Revvity Price Target to $165 From $125	MT
10-06	Barclays Adjusts Price Target on Revvity to $160 From $115, Maintains Equalweight Rating	MT
10-06	William Blair Initiates Revvity at Outperform	MT
09-24	Leerink Partners Adjusts Revvity Price Target to $160 From $145, Maintains Outperform Rating	MT
09-21	Goldman Sachs Adjusts Price Target on Revvity to $140 From $100, Keeps Neutral Rating	MT
09-21	Analyst recommendations: Flutter, Constellation Brands, CoreWeave, eBay, Meta Platforms…
09-09	UBS Downgrades Revvity to Neutral From Buy, Adjusts Price Target to $140 From $120	MT
09-04	KeyBanc Adjusts Price Target on Revvity to $165 From $125, Maintains Overweight Rating	MT
09-04	Analyst recommendations: Microsoft, DocuSign, Intuit, Lululemon Athletica, Zscaler…
09-03	Baird Adjusts Price Target on Revvity to $144 From $131, Keeps Outperform Rating	MT
09-01	Revvity Faces Growth Challenges Amid Rising Competition, RBC Says	MT
09-01	RBC Initiates Revvity at Sector Perform With $135 Price Target	MT
08-05	Bernstein Adjusts Price Target on Revvity to $120 From $115, Maintains Market Perform Rating	MT
08-05	Evercore ISI Adjusts Price Target on Revvity to $126 From $125, Maintains Outperform Rating	MT
08-05	Jefferies Adjusts Price Target on Revvity to $112 From $102, Maintains Hold Rating	MT
08-05	Barclays Adjusts Price Target on Revvity to $115 From $105, Maintains Equalweight Rating	MT
08-05	JPMorgan Adjusts Price Target on Revvity to $110 From $90	MT
08-05	Stifel Adjusts Price Target on Revvity to $110 From $100	MT
08-05	Analyst recommendations: Palantir Technologies, McDonald's, Booking Holdings, Arista Networks, Amgen...
07-15	TD Cowen Adjusts Price Target on Revvity to $130 From $120, Maintains Buy Rating	MT
07-13	Baird Adjusts Price Target on Revvity to $128 From $117, Maintains Outperform Rating	MT
07-06	Evercore ISI Adjusts Price Target on Revvity to $125 From $110	MT

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	REVVITY, INC.					-3.02%
	THERMO FISHER SCIENTIFIC, INC.					+2%
	DANAHER CORPORATION					+8.65%
	INTUITIVE SURGICAL, INC.					+13.77%
	BOSTON SCIENTIFIC CORPORATION					+38.01%
	SIEMENS HEALTHINEERS AG					+13.87%
	EDWARDS LIFESCIENCES CORPORATION					+17.94%
	VEEVA SYSTEMS INC.					-0.11%
	AGILENT TECHNOLOGIES, INC.					+3.62%
	WATERS CORPORATION					+5.3%
	Average					+10.00%
	Weighted average by Cap.					+9.39%